Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders
NCT ID: NCT06044363
Last Updated: 2023-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2023-09-01
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Family-based Intervention for Drug-abusing Adults in Hong Kong
NCT04725266
The Follow-up Study for the Patients of Illicit Substance Use Disorder
NCT04426565
Equine-assisted Therapy Effectiveness in Improving Emotion Regulation of Patients Suffering From Substance Use Disorder
NCT05632185
Motivational Interviewing to Reduce Substance Use Among Depression Patients
NCT02420561
Impact of Exercise and Affirmations (IntenSati) on Addiction-related Cognitive and Psychosocial Deficits
NCT01171677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Satir group
Participants in the intervention group will receive a 10-session Satir model intervention.
Satir group
Participants in the intervention group will receive a 10-session, 3-hour/session intervention that spans over a period of five days (2 sessions/day). The intervention program will be conducted on specific weekends, with a gap of 1 to 2 weeks. The total duration of the intervention will be 30 hours.
Control group
Participants in the control group will receive care as usual.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Satir group
Participants in the intervention group will receive a 10-session, 3-hour/session intervention that spans over a period of five days (2 sessions/day). The intervention program will be conducted on specific weekends, with a gap of 1 to 2 weeks. The total duration of the intervention will be 30 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. are able to speak, read, and write Chinese;
3. are willing to participate in the study and share their experience of the intervention with the research group;
4. have informed consent to participate in the study.
Exclusion Criteria
2. have a diagnosed memory and cognitive impairment;
3. are undergoing psychotherapeutic or psychopharmacologic treatment;
4. are participating in similar studies.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hong Kong Metropolitan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Polly MA Haixia
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haixia Ma, PhD
Role: PRINCIPAL_INVESTIGATOR
Hong Kong Metropolitan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fangqiang compulsory isolation detoxification center
Yancheng, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HE-SF2023/26
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.